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In Brief
Reduced thyroid hormone (TH) and
growth hormone (GH) activity are
hallmarks of genetic models of longevity
in mice. Here, Hine et al. find that TH and
GH negatively regulate hepatic
production of the longevity-associated
gas hydrogen sulfide, which feeds back
to negatively regulate circulating TH and
IGF-1 levels.
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Decreased growth hormone (GH) and thyroid hor-
mone (TH) signaling are associated with longevity
and metabolic fitness. The mechanisms underlying
these benefits are poorly understood, but may over-
lap with those of dietary restriction (DR), which im-
parts similar benefits. Recently we discovered that
hydrogen sulfide (H2S) is increased upon DR and
plays an essential role in mediating DR benefits
across evolutionary boundaries. Here we found
increased hepatic H2S production in long-lived
mouse strains of reduced GH and/or TH action, and
in a cell-autonomousmanner upon serumwithdrawal
in vitro. Negative regulation of hepatic H2S produc-
tion by GH and TH was additive and occurred via
distinct mechanisms, namely direct transcriptional
repression of the H2S-producing enzyme cystathio-
nine g-lyase (CGL) by TH, and substrate-level control
of H2S production by GH. Mice lacking CGL failed to
downregulate systemic T4 metabolism and circu-
lating IGF-1, revealing an essential role for H2S in
the regulation of key longevity-associated hormones.1320 Cell Metabolism 25, 1320–1333, June 6, 2017 ª 2017 The Auth
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Hydrogen sulfide (H2S) affects numerous aspects of animal
physiology (Wang, 2012), including long-term potentiation in
the nervous system (Abe and Kimura, 1996), vasorelaxation
(Zhao et al., 2001), oxygen sensing (Olson et al., 2006), angio-
genesis in the cardiovascular system (Cai et al., 2007;
Papapetropoulos et al., 2009), and insulin secretion from
endocrine cells in the pancreas (Yang et al., 2005). While
H2S at high concentrations is toxic, low levels impart
numerous benefits including resistance to hypoxia (Black-
stone and Roth, 2007), neuroprotection (Kimura and Kimura,
2004), protection from myocardial ischemia reperfusion injury
(Bian et al., 2006; Elrod et al., 2007), modulation of inflamma-
tion (Zanardo et al., 2006), and extension of longevity (Miller
and Roth, 2007). H2S is also produced endogenously by
several enzymes, including 3-MST and the transsulfuration
pathway (TSP) enzymes cystathionine b-lyase (CBS) and
cystathionine g-lyase (CGL) (Kabil et al., 2011). Mice lacking
functional TSP activity are hypertensive (Yang et al., 2008),
display reduced angiogenic potential (Szabo´ and Papapetro-
poulos, 2011), and are susceptible to aging-related neurode-
generation and osteoporosis (Liu et al., 2014; Paul et al.,
2014). Despite the implications for its pleiotropic beneficialors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
effects, little is known about the systemic regulation of endog-
enous H2S production.
Previously, we reported that dietary restriction (DR), best
known for increasing lifespan, stress resistance, and metabolic
fitness in organisms across evolutionary boundaries, works
partially through increasing endogenous H2S production (Hine
et al., 2015). In rodents, DR-mediated protection from hepatic
ischemia reperfusion injury requires H2S generation by CGL,
which is subject to regulation by sulfur amino acid intake (Hine
et al., 2015; Nakano et al., 2015; Sikalidis and Stipanuk, 2010).
Downstream mechanisms of H2S action in this context, and
whether these are specific to DR or shared with other anti-aging
interventions, remain unknown.
Like DR, reduced hypothalamic-pituitary axis activity is
associated with resistance to age-related diseases, extended
longevity, and improved metabolic fitness in rodents and
humans. Long-lived rodent strains include hypopituitary Snell
and Ames dwarf mice that lack growth hormone (GH) and
thyroid-stimulating hormone (TSH) (Bartke and Brown-Borg,
2004). Specific ablation of the GH receptor (GHR) in GHR
knockout mice (GHRKO) also increases lifespan, suggesting
the specificity of the GH pathway in aging (Coschigano et al.,
2003). However, TH levels are also reduced in GHRKO mice,
complicating the functional dissection of GH and TH activity in
longevity control in vivo (Hauck et al., 2001). Subclinical hypo-
thyroidism is associated with longevity in human centenarian
studies (Atzmon et al., 2009; Rozing et al., 2010), and inactiva-
ting mutations in GHR are associated with metabolic fitness
and reduced cancer incidence in humans (Guevara-Aguirre
et al., 2011).
GHRKO mice are recalcitrant to further increase in lifespan or
insulin sensitivity upon DR, consistent with at least partially
overlapping mechanisms of action (Bonkowski et al., 2006).
One such candidate mechanism is the insulin-like growth fac-
tor-1 (IGF-1) pathway, which is reduced upon DR as well as in
hypopituitary/GHRKO longevity models. Here, we tested the hy-
pothesis that increased H2S production is a shared phenotype
in genetic models of longevity involving decreased GH/TH
signaling with the potential to contribute to metabolic benefits.
We found that GH and TH negatively regulate hepatic H2S
production through distinct mechanisms, with functional con-
sequences on feedback control of hepatic IGF-1 and TH
production.
RESULTS
Increased Hepatic H2S Production in Long-Lived
Hypopituitary Dwarf Mice In Vivo
We examined the impact of reduced GH and TSH signaling on
hepatic CGL and CBS mRNA and protein expression and H2S
production capacity in Snell dwarf mice lacking these hormones
(Figures 1A–1D). Male and female Snell dwarf mice had in-
creases in hepatic CGL mRNA (Figure 1A) and protein (upper
band) compared with wild-type (WT) littermates (Figure 1B). He-
patic CBS mRNA was not increased in either male or female
mice (Figure 1A), but CBS protein levels were increased in
male mice compared with WT littermates (Figure 1B). Consistent
with enzyme levels, H2S production capacity, as measured by
the lead sulfide method, was increased in liver homogenatesin both male and female Snell dwarf mice (Figure 1C). Impor-
tantly, endogenous H2S levels, as detected by two-photon mi-
croscopy using the H2S-specific chemo-fluorescent probe P3
(Singha et al., 2015), were also increased in Snell dwarf livers
(Figure 1D).
To test if increased H2S production could have functional
consequences on hypopituitary dwarf mice, we made use of
the fact that GH treatment of Ames dwarf mice during early
post-natal development (weeks 2-8) reverses lifespan andmeta-
bolic effects (Panici et al., 2010). Early GH treatment normalized
(reduced) hepatic H2S production capacity (Figure 1E) and CGL
protein levels (Figure S1A) measured later in life at 18 months of
age. These data demonstrate a correlation between hepatic H2S
production capacity and longevity in the Ames dwarf model.
Because Snell and Ames dwarf mice lack GH and TH signals
from birth, we next tested the plasticity of H2S regulation by
GH/TH in WT adult mice by pharmacological inhibition with the
somatostatin analog, lanreotide (Kuhn et al., 1994). Treatment
for 8 days increased liver H2S production capacity (Figure 1F)
and CGL protein levels (Figure S1B) without affecting body
weight (Figure S1C) or food intake (Figure S1D). These data
demonstrate that GH and TSH deficiency/inhibition promote he-
patic H2S production in vivo.
GH Signaling Inhibits Hepatic H2S Production In Vivo
We next focused specifically on the potential of GH to regulate
H2S production using global GHRKO mice. Male and female
GHRKO mice had increases in hepatic CGL mRNA and protein
relative to WT littermates (Figures 2A and 2B). As in Snell dwarf
mice, CBS protein was increased in GHRKO males, while CBS
mRNA expression was unchanged (Figures 2A and 2B). Hepatic
H2S production capacity was increased in both male and fe-
male GHRKO mice compared with WT littermates (Figure 2C).
Thus, the lack of GH signaling due to global deletion of its re-
ceptor results in increased hepatic H2S production capacity
in vivo.
As IGF-1 is a major downstream effector of hepatic
GH signaling, we tested the effects of 2 weeks of recom-
binant human IGF-1 or human GH injections on hepatic H2S
production capacity and CGL protein expression. While
IGF-1 had no effect relative to mock treatment, GH injec-
tion reduced hepatic H2S production capacity (Figure 2D)
and hepatic CGL protein expression (Figure S2A). Consistent
with GH-mediated repression of H2S production capacity,
GH injection suppresses CGL mRNA expression accord-
ing to independent data obtained from NCBI GeoProfile
GDS862/8.2.2.10/Cth (Ahluwalia et al., 2004) (Figure S2B).
Together, these data indicate that GH and GHR signaling
suppress hepatic H2S production capacity in vivo indepen-
dent of IGF-1.
To confirm the specific role of GHR signaling in H2S regula-
tion, we tested the potential of two intracellular mediators
of hepatic GHR signaling, IRS-1 and FGF21, to alter H2S
production. IRS-1 is an adaptor protein involved in both insulin
and GHR signaling (Liang et al., 1999), and global IRS-
1KO mice are long lived (Selman et al., 2011). IRS-1KO mice
had increased hepatic H2S production capacity (Figure 2E)
and elevated CGL protein expression (Figure S2C). Because
IRS-1KO mice are insulin resistant (Biddinger et al., 2008),Cell Metabolism 25, 1320–1333, June 6, 2017 1321
Figure 1. Increased Hepatic H2S Production in Long-Lived Hypopituitary Dwarf Mice In Vivo
(A–D) Hepatic CGL and CBSmRNA expression (n = 3/group) (A), protein expression (n = 3/group) (B), H2S production capacity via the lead sulfide method (n = 3/
group) (C), and endogenous H2S production via two-photon florescence microscopy (n = 3/group) (D) in male and female WT or Snell dwarf mice as indicated.
Scale bar, 25 mm. Asterisk indicates the significance of the difference between genotypes within sex; *p < 0.05.
(E) Liver H2S production capacity in 18-month-old female Ames dwarf or WT mice treated +/ growth hormone during postnatal development at weeks 2-8
(n = 9–14/group). The asterisk indicates the significance of the difference between theWT+Saline control group and experimental group, and the # sign indicates
the significance of the difference between +Saline and +GH; */#p < 0.05.
(F) Liver H2S production capacity in mice treated with saline control or lanreotide (n = 4/group). The asterisks indicate the significance of the difference between
treatment groups; *p < 0.05. Error bars are ± SEM. See also Figure S1.we tested the potential contribution of insulin receptor (IR)
signaling using liver-specific insulin receptor knockout (LIRKO
mice). However, LIRKO mice displayed decreased hepatic
H2S production capacity (Figure S2D), consistent with GH
signaling rather than IR signaling in negative regulation of
hepatic H2S production. In addition, long-lived mice overex-
pressing the fasting hormone FGF21 (Zhang et al., 2012), an
intracellular inhibitor of GH signaling (Inagaki et al., 2008), dis-
played increased hepatic H2S production capacity (Figure 2F)
and CGL protein (Figure 2E). These data are consistent with
GH/GHR as a negative regulator of H2S production capacity,
and show a positive correlation between increased hepatic
H2S production capacity and extended longevity in vivo.
GH/GHR Signaling Inhibits Hepatic H2S Production
In Vitro
To elucidate how GHR signaling controls H2S production, we
turned to overnight serum withdrawal with or without added
recombinant GH in cell culture as a cell-autonomous model.
Endogenous H2S production was measured using the fluores-1322 Cell Metabolism 25, 1320–1333, June 6, 2017cent P3 probe and visualized/quantitated by two-photon mi-
croscopy or UV spectrophotometry. We first established the
ability of overnight serum withdrawal to induce robust endog-
enous H2S production, and the specific contribution of TSP
enzymes CGL and CBS to this process using WT versus
CGLKO fibroblasts with or without PAG and AOAA, inhibitors
of CGL and CBS, respectively (Figures S3A and S3B). Interest-
ingly, while CGL is the predominant H2S producer in liver
in vivo (Kabil et al., 2011), and responsible for the increase
in H2S production capacity in response to DR (Hine et al.,
2015), CBS also contributed to the increase in H2S pro-
duction upon serum withdrawal in primary fibroblasts in vitro
(Figure S3A).
In cultured mouse primary hepatocytes, H2S production was
also significantly increased upon serum deprivation (Figures 3A
and S3C). Importantly, addition of recombinant GH at the level
required to induce robust phosphorylation of Stat5 (p-Stat5),
and transcription of Igf-1 (Figure S3D–S3F), dampened the
increase in H2S production induced by serum deprivation
(Figures 3A and S3C).
Figure 2. Growth Hormone Signaling Inhibits Hepatic H2S Production In vivo
(A–C) Hepatic CGL and CBS mRNA expression (n = 3/group) (A), protein expression (n = 3/group) (B), and H2S production capacity (n = 3/group) (C) in male and
female growth hormone receptor knockout (GHRKO) mice. The asterisk indicates the significance of the difference between genotypes within sex; *p < 0.05.
(D) Liver H2S production capacity (n = 8/group) in WT mice treated for 2 weeks with recombinant IGF-1, GH, or saline vehicle as indicated. The asterisk indicates
the significance of the difference between GH and saline treatment; *p < 0.05.
(E and F) Liver H2S production capacity in male and female IRS-1 WT or KOmice (n = 4–11/group) (E) and in male FGF21 WT or overexpressing (OE) mice (n = 6/
group) (F). The asterisk indicates the significance of the difference between genotypes within sex; *p < 0.05. Error bars are ± SEM. See also Figure S2.Canonical GH-induced intracellular signaling begins with its
binding to and dimerization of the GHR on the plasma mem-
brane, leading to stimulation of numerous signaling cascades,
including Jak2/Stat5, followed by the transcriptional/transla-
tional regulation of target genes such as Igf-1. While addition
of GH into medium containing serum did not change H2S pro-
duction, blocking GH signaling with the Jak2 inhibitor AZD1480
(Gu et al., 2013) moderately increased endogenous H2S in hepa-
tocytes cultured in Complete medium with additional GH (Fig-
ures 3B and S3G). Furthermore, the increase in H2S production
induced by serum deprivation and blocked by GH was fully
restored with addition of AZD1480 (Figures 3B and S3G). Exog-
enous FGF21 increased H2S production despite the presence of
full serum (Figures 3C and S3H). Together, these data suggest
that GH acts through the Jak2/Stat5 pathway to repress H2S
production in cells.
Because of increased TSP mRNA/protein expression in Snell/
Ames and GHRKO livers in vivo, we next asked if GH regulates
hepatic H2S production in a cell-autonomous manner via tran-
scriptional control of TSP gene expression, in a manner similar
to control of Igf-1 (Figure 3D). Surprisingly, serum withdrawal
from primary hepatocytes failed to increase CGL mRNA or pro-tein to the same levels as observed in vivo (Figures S3I and S3J).
Similarly, pharmacological inhibition of GH/GHR action with
AZD1480 or FGF21 failed to significantly affect TSP gene
expression as they did IGF-1 expression (Figure 3D). Together,
these data suggest that neither transcriptional nor translational
control of CBS or CGL are the major mechanisms of hepatic
H2S regulation by GH in cells.
Regulation of endogenous H2S production via CBS and
CGL in cells could instead occur post-translationally or be
driven by substrate availability (Kabil et al., 2011; Majtan
et al., 2014; Zhao et al., 2014). While the endogenous source
of free cysteine for H2S production is currently unknown,
cellular autophagy is increased in long-lived dwarf mice
(Wang and Miller, 2012), thus potentially fueling the increase
in H2S production observed upon GH signaling inhibition.
Consistent with this notion, pharmacological inhibition of
autophagy with bafilomycin (BAF) or chloroquine (CQ) blocked
H2S production induced by serum removal (Figures 3E, 3F,
S3K, and S3L), even in the presence of media lacking sulfur
amino acids (SAA) (Figure 3F). Similarly, inhibition of auto-
phagy by genetic knockdown (Figures 3G, S3M) or knockout
(Figure 3H and S3N) of Autophagy Protein 5 (ATG5) or 7Cell Metabolism 25, 1320–1333, June 6, 2017 1323
Figure 3. Growth Hormone Receptor Signaling Inhibits Hepatic H2S Production In Vitro
(A–C) Endogenous H2S production in primary mouse hepatocytes as measured via two-photon fluorescent microscopy under different medium conditions:
(A) +/growth serum and +/GH, with the asterisk indicating the significance of the difference between Complete and Serum, and the # sign indicating the
significance of the difference between Serum and Serum+GH, */#p < 0.05; (B) +/growth serum, +/GH, +/AZD1480, with the asterisk indicating the
significance of the difference between Complete andSerum in each group, and the # sign indicating the significance of the difference betweenSerum () (no
addition) and Serum+ZD1480; and the $ sign indicating the significance of the difference between +GH and +GH+ZD1480 for both Complete and Serum
conditions, */#/$p < 0.05; (C) +/FGF21 in Complete medium containing serum, with the asterisk indicating the significance of the difference between Complete
and Complete+FGF21; *p < 0.05.
(D) mRNA expression of Igf-I, Cgl, and Cbs in mouse primary hepatocytes. The asterisk indicates the significance of the difference between +GH and +GH+
ZD1480; *p < 0.05.
(E and F) Endogenous H2S production in mouse primary hepatocytes by florescent microscopy after overnight treatment under the indicated medium conditions
followed by addition of the P3 probe for 1 hr. The asterisk indicates the significance of the difference between Complete andSerum, and the # sign indicates the
significance of the difference between Serum and Serum+BAF (E), or SerumSAA and SerumSAA+CQ (F); *#p < 0.05.
(G and H) Endogenous H2S production in Hepa1-6 cells with or without knockdown of autophagy components ATG5 and ATG7 by shRNA (G) or in MEFs by
genetic knockout of ATG5 and ATG7 (H) detected by UV spectrophotometry after overnight treatment with or without serum followed by addition of the P3 probe
for 1 hr. The asterisk indicates the significance of the difference between Complete andSerum in the Control group, and the # sign indicates the significance of
the difference between Serum Control andSerum ATG5 deficient orSerum ATG7 deficient; */#p < 0.05. Each experiment was repeated at least three times.
Scale bars, 100 mm (A–C, E, and F). Error bars are ± SEM. See also Figure S3.(ATG7) decreased H2S production upon serum withdrawal.
Taken together, these data suggest that GH is a nega-
tive regulator of H2S production in vitro through auto-
phagy-dependent substrate-level and/or enzymatic activity
control rather than transcriptional control of CGL and CBS
expression.1324 Cell Metabolism 25, 1320–1333, June 6, 2017Hypothyroidism Increases Hepatic H2S Production
In Vivo
We next considered the potential of TH to explain the transcrip-
tional control of hepatic CGL expression observed in these
models in vivo but not readily attributable to GHR activity
in vitro. Adult male mice were made hypo-, eu-, or hyperthyroid
Figure 4. Hypothyroidism Increases and Thyroid Hormone Represses Hepatic H2S Production In Vivo
(A–D) mRNA expression (n = 4) (A), protein expression (n = 3) (B), H2S production capacity (n = 4) (C), and transmethylation/transsulfuration metabolite levels by
liquid chromatography-tandemmass spectrometry (n = 4) (D) in livers of mice under hypo- (PTU+Saline), hyper- (PTU+high dose T3), and eu-(PTU+low dose T3)
thyroid states. The asterisks indicate the significance of the difference from the hypothyroid state (PTU+Saline); *p < 0.05.
(E–G) Analysis of TH-responsive and sulfur amino acid metabolism-associated mRNA levels (n = 4–6) (E), protein expression (n = 5) (F), and H2S production
capacity (n = 5) (G) in livers of mice treatedwith T3 (hyperthyroid) versus vehicle (saline) control (euthyroid). The asterisk indicates the significance of the difference
between vehicle and +T3 groups; *p < 0.05. Error bars are ± SEM. See also Figure S4.by inhibiting endogenous thyroid function with a PTU-containing
low iodine diet (PTU/LID) with or without TH supplementation (in
the form of T3). To validate the system, we confirmed that known
TH target genes were regulated as expected in the hypothyroid
(PTU/LID), euthyroid (PTU/LID + low dose T3), and hyperthyroid
(PTU/LID + high dose T3) states (Figure S4A).
Circulating T3 levels strongly correlated with expression of
genes in the methionine cycle and TSP including CGL, which
was activated in the hypothyroid state and strongly repressed
by increasing doses of T3 (Figure 4A). A similar correlation was
observed between T3 and hepatic protein levels of CGL and
CBS (Figure 4B) as well as hepatic H2S production capacity (Fig-
ures 4C and S4B). Metabolomics revealed broader effects
of circulating T3 on hepatic methionine cycle and TSP metabo-
lites, including regulation of homocysteine, cystathionine, and
cysteine (Figure 4D). Finally, we confirmed that T3 alone, without
the induction of hypothyroidism via a PTU/LID, reduced hepaticCGL and CBS mRNA (Figure 4E), correlating with protein levels
(Figure 4F), hepatic H2S production capacity (Figure 4G) and
characteristic changes in hepatic metabolites, including cysta-
thionine and cysteine (Figure S4C).
Thyroid Hormone Signaling through TRb Suppresses
Hepatic H2S Production
While T3 acts broadly in vivo through multiple TH receptors, its
action in liver depends primarily on TH receptor b1 (TRb1). To
test if negative regulation of TSP expression and H2S production
capacity by T3 is organ autonomous or the result of systemic T3
action, we took advantage of the T3 analog GC-1, which prefer-
entially acts on the liver via its uptake and specificity for TRb1.
GC-1 predictably modulated known T3 target genes in the liver
(Figure 5A, left) and negatively regulated components of the he-
patic methionine cycle and TSP, including CGL and CBS gene
and protein expression (Figures 5A and 5B). GC-1 also reducedCell Metabolism 25, 1320–1333, June 6, 2017 1325
Figure 5. Thyroid Hormone Signaling through TRb Represses Hepatic H2S Production In Vivo
(A–C) Analysis of TH-responsive and sulfur amino acid metabolism-associated mRNA levels (n = 4–6) (A), protein expression (n = 6) (B), and H2S production
capacity (n = 5) (C) in livers of mice treated with GC-1 versus vehicle (saline) control. The asterisk indicates the significance of the difference between vehicle
(saline) control (euthyroid) and +GC-1 groups (hyperthyroid); *p < 0.05.
(D and E) Liver CBS and CGL protein expression (D) and H2S production capacity (E) in mice with indicated TRb status (WT, homozygous WT; TRb
PV/+, Het;
TRbPV/PV, homozygous mutant; n = 4–5/group). The asterisk indicates the significance of the difference between WT and TRbPV/PV, and the # sign indicates the
significance of the difference between TRbPV/+ and TRbPV/PV; */#p < 0.05.
(F) Fold enrichment of TRb binding to genetic regulator elements in sulfur amino acid metabolism and H2S producing genes in the livers of mice infected with Ad-
GFP (control) or Ad-TRb while on PTU diets +/T3 injection as indicated (n = 5/group). The asterisk indicates the significance of the difference between the Ad-
GFP PTU and Ad-TRb PTU or Ad-TRb T3 groups, and the # sign indicates the significance of the difference between the Ad-TRb PTU and Ad-TRb T3 groups;
*/#p < 0.05.
(G and H) Liver ATF4 protein expression in mice due to PTU/T3 administration (G) (n = 4/group) or TRb mutations (H) (n = 4–5/group). The asterisks indicate the
significance of the difference between Hyper-T and Eu-T or Hypo-T (G), or WT and TRbPV/+ or TRbPV/PV (H), and the # sign indicates the significance of the
difference between TRbPV/+ and TRbPV/PV (H), */#p < 0.05. Error bars are ± SEM. See also Figure S5.hepatic H2S production capacity (Figure 5C) and altered he-
patic TSP metabolites, including cystathionine, similar to T3
(Figure S5A).
The genetic requirement for TRb1 in repression of hepatic TSP
expression and H2S production was tested in mice with amutant
and defective TRb1 isoform (TRbPV/PV) (Zhao et al., 2012).
TRbPV/PV mice had higher CGL and CBS protein levels in the liver
and enhanced H2S production capacity than heterozygote or
WT control animals (Figures 5D and 5E). Interestingly, neither
CGL nor CBS mRNA levels were significantly altered in the1326 Cell Metabolism 25, 1320–1333, June 6, 2017TRbPV/PV mice compared with controls (Figure S5B), possibly
due to long-term upregulation of this pathway in these animals.
Thus, an intact TRb regulates H2S production, but it also remains
possible that TRa plays a role in TRbPV/PV mutants.
Finally, to test the hypothesis that TRb1 regulates H2S produc-
tion capacity by direct transcriptional control of TSP genes
in vivo, we examined the TRb cistrome that we generated previ-
ously (Ramadoss et al., 2014) for binding sites within regulatory
regions of the CBS and CGL genes. Chromatin immunoprecipi-
tation analysis revealed enrichment of TRb binding at several
Figure 6. Additive Suppression of Hepatic H2S Production by TH and GH In Vitro
(A–C) mRNA levels (n = 3) (A), protein expression (n = 3) (B), and endogenous H2S production (n = 3) (C) in TH-responsive Hepa1-6 cells treated with T3 at the
indicated concentration. The asterisk indicates the significance of the difference between vehicle control and T3 treatment and the hash indicates the significance
of the difference between different T3 dosage groups; */#p < 0.05.
(D) Endogenous H2S production in TH-responsive Hepa1-6 cells grown in Complete medium or Serum medium +/GH +/T3. The asterisk indicates the
significance of the difference between Complete and Serum within the GH/T3 treatment group, and the # sign indicates the significance of the difference
between ‘‘w/out Additions’’ and +GH, +T3, or +GH+T3 groups within theSerum grouping; */#p < 0.05. Scale bars, 100 mm (C and D). Error bars are ± SEM. See
also Figure S6.loci on the CBS and CGL genes, as well as other genes of the
methionine cycle (Figure 5F). Interestingly, T3 injection resulted
in a significant reduction in occupancy of TRb on CGL and
Bhmt promoters/enhancers, but not CBS binding sites. While
the detailed mechanisms of negative regulation of hepatic TSP
gene expression by T3 and TRb1 remain to be elucidated, these
data suggest regulation of hepatic H2S production via TRb-de-
pendent repression of TSP gene expression.
In addition to negative regulation by T3/TRb as described here,
CGL gene expression is positively regulated by the stress
response transcription factor ATF4 in reaction to cysteine re-
striction on the cell-autonomous level (Lee et al., 2008; Sikalidis
et al., 2011) and in livers of mouse models of DR and Snell
dwarfism (Li et al., 2014). Surprisingly, we found that reduction
of global TH signaling via a PTU/LID diet (Figure 5G), or liver-
specific signaling in TRbPV/PV mice (Figure 5H), increased
hepatic ATF4 protein levels. Despite the increase in hepatic
ATF4 protein in Snell dwarf mice (Figure S5C), we were not
able to detect significantly elevated levels in GHRKO mice (Fig-
ure S5D). Thus, hyperthyroidism is associated with negative
regulation of CGL expression through direct binding and repres-
sion of the CGL locus by T3-bound TRb1, while hypothyroidism
is associated with increased CGL expression indirectly through
derepression of the transcriptional activator ATF4, possibly by
hypothyroidism-induced endoplasmic reticulum stress (Zhou
et al., 2016).Additive Suppression of Hepatic H2S Production by TH
and GH In Vitro
Having identified GH- and TH-dependent control of hepatic H2S
production capacity, we next sought to determine the potential
interaction between the two in a tractable in vitro system.
Because primary murine hepatocytes do not respond well to
T3, we employed a murine hepatic cell line, Hepa1-6, stably
transfected with the TRb isoform. Upon addition of T3 to this
cell line, known T3 targets including gpd2 and bcl3 were induced,
while methionine cycle genes mat1a and ahcy were repressed
(Figure 6A). Importantly, both CGL and CBS were downregu-
lated by T3 in these cells (Figure 6A), although only CGL was
regulated in a similar fashion at the protein level (Figure 6B).
Endogenous H2S production assessed using the P3 probe was
reduced upon T3 addition, confirming its direct ability to regulate
endogenous H2S through repression of CGL mRNA expression
(Figure 6C).
We next tested the individual and combined contributions of
GH and TH in regulation of endogenous H2S production in this
cell line. Overnight serum withdrawal resulted in a 2.5-fold in-
crease in endogenous H2S levels (Figure 6D). Addition of GH
or TH individually each resulted in a 50% decrease in H2S levels,
while together they restored H2S to baseline levels seen in cells
maintained in full serum (Figure 6D). Finally, gene expression
analysis confirmed the effects of TH, but not GH, on TSP gene
expression (Figure S6). Taken together, GH and TH workCell Metabolism 25, 1320–1333, June 6, 2017 1327
additively to suppress hepatic H2S production in a cell-autono-
mous manner by distinct mechanisms.
CGL/H2S Required for Negative Regulation of TH and
GH/IGF-1 Signaling
What are the functional consequences of increased H2S produc-
tion in the context of reduced GH and/or TH signaling? We first
approached this question by testing the genetic requirement
for CGL in increased hepatic H2S production observed upon
hypothyroidism. CGL protein and H2S production capacity
were increased in hypothyroid WT mice on the PTU/LID diet
compared with euthyroid WT mice on the normal diet, but
were undetectable in littermate CGL KO mice on either diet (Fig-
ures 7A and 7B, and Figure S7A). No differences in food intake
(Figure S7B), body weight (Figure S7C), or protein levels of the
other H2S-producting enzymes CBS and 3-MST (Figures 7A
and S7A) were observed between genotypes. We conclude
that CGL is required for increased hepatic H2S production
upon decreased TH signaling.
Surprisingly, CGL KO mice failed to achieve the same degree
of hypothyroidism as WT controls on the PTU/LID diet. This was
first observed systemically upon measuring circulating T4, which
remained elevated in CGL KO mice on the PTU/LID diet (Fig-
ure 7C), and was confirmed by TSHb subunit gene expression
in the pituitary (Figure 7D) and circulating TSH in the serum (Fig-
ure 7E), both of which failed to increase in CGL KO mice to WT
levels on the PTU/LID diet.
These data suggest a functional role for CGL-derived H2S in
systemic feedback control of TH signaling, possibly through
modulation of circulating T4 levels. To test this further, CGL KO
and WT mice were subject to fasting, a known suppressor of
the hypothalamic-pituitary-thyroid axis on a more rapid time-
scale than the PTU/LID paradigm (Vella et al., 2011). While
serum T4 levels decreased in WT mice subject to a 3-day fast,
T4 levels actually increased slightly upon fasting in CGL KO
mice (Figure 7F), despite similar weight loss between genotypes
(Figure S7D). Taken together, these data suggest reciprocal
negative regulation of H2S production by TRb-dependent
repression of hepatic CGL gene transcription, and T4 meta-
bolism by CGL-derived H2S.
We next considered the potential role of CGL-derived H2S in
negative regulation of global and hepatic GH action. In CGL
KO mice, expression of pituitary GH mRNA (Figure 7G), hepatic
GHR and IGF-1 mRNAs (Figure 7H), and circulating IGF-1 levels
(Figure 7I) were inappropriately maintained and/or elevated upon
PTU/LID relative to WT mice. Similar to its effects on circulating
T4, fasting significantly decreased serum IGF-1 in WT mice, but
not in CGL KO mice (Figure 7J).
Finally, we tested the sufficiency of CGL-derived H2S or chem-
ical H2S donors to lower GH signaling independent of PTU/LID or
fasting. One week after adenoviral-mediated CGL overexpres-
sion inWTmice, which resulted in increased liver H2S production
capacity (Figure S7E), serum IGF-1 levels were significantly
reduced relative to the adenoviral null control (Figure 7K).
In CGL KOmice subjected to a 2-day fast, intraperitoneal admin-
istration of NaHS rescued the expected drop in serum IGF-1
levels (Figure 7L) and serum T4 levels (Figure S7F). In WT
mice, NaHS was sufficient to reduce circulating IGF-1 levels
after acute injection (Figure S7G) or long-term treatment in the1328 Cell Metabolism 25, 1320–1333, June 6, 2017drinking water in combination with the slow-releasing H2S donor
GYY4137 (Lee et al., 2011) (Figure S7H). These findings are
consistent with a role for CGL-derived endogenous H2S in nega-
tive regulation of GH and TH signaling.
DISCUSSION
H2S as a Common Endpoint in Models of Longevity and
Metabolic Homeostasis
Reduced GH/IGF-1 action and DR represent the most widely
studied classes of anti-aging models in rodents, but mecha-
nisms underlying pleiotropic benefits on lifespan, healthspan,
and stress resistance in these models, and the relationship be-
tween them, remain unclear. Previously we found that increased
endogenous H2S production upon DR is necessary and suffi-
cient for surgical stress resistance in mice, and associated
with extended longevity in fly, worm, and yeast models (Hine
et al., 2015). Here, we found that increased endogenous hepatic
H2S production capacity was common to multiple long-lived
mouse strains. As shown in the model in Figure 7M, GH and
TH signaling were identified as negative regulators of hepatic
H2S production. Unexpectedly, CGLwas required for downregu-
lation of T4 and IGF-1 in response to PTU/LID or fasting. Taken
together, these data are consistent with increased hepatic H2S
as a common denominator among DR and reduced GH/IGF-1-
based pro-longevity models. Further, it points to negative regu-
lation of TH and GH/IGF-1 signaling as a potential mechanism of
H2S action in this context.
A limitation of this study lies in the quantitation of H2S levels.
Much of the data was based on H2S production capacity using
the lead acetate method, a measure of H2S production under
conditions in which exogenous substrate (L-Cys) and co-factor
(VitB6) are supplied in excess. While specific for H2S and sensi-
tive for use in organ extracts with high production capacity, the
more sensitive P3 fluorescent probe was required for measuring
H2S production in individual cells in tissue culture or frozen liver
sections. Importantly, the P3 probe reports on free H2S either
generated de novo or released from sulfane sulfur without the
addition of substrate or co-factor, thus making it possible to
probe actual H2S production with endogenous substrates. While
neither method is suited for absolute quantitation of H2S, both
techniques showed increases in liver of Snell dwarf mice versus
WT controls. Finally, while the importance of CGL-derived H2S
was addressed by exogenous H2S supplementation in the
context of CGL KO mice, our data in no way rule out potential
contributions of other CGL-dependent metabolites such as
glutathione.
Interactions between Nutrient Restriction, Endocrine
Signaling, and H2S Production
DR benefits overlap those of reduced GH/TH signaling, and
indeed DR has been proposed to work, at least partially, the hy-
pothalamic-pituitary axis, through modulation of somatotropic
cells (Brown-Borg, 2015). The ability of DR to further extend
longevity or improve metabolic fitness is blunted in most, but
not all (Bartke et al., 2001), hypopituitary or GHRKO mouse
studies (Arum et al., 2009; Bonkowski et al., 2006; Brown-Borg
et al., 2014). In addition, GH supplementation concurrent with
DR reverses some DR-related metabolic effects (Gesing et al.,
Figure 7. CGL/H2S Is Required for Negative Regulation of TH and GH/IGF-I Signaling
(A and B) Western blot analysis of H2S-producing enzymes CGL, CBS, and 3MST (n = 3) (A) and H2S production capacity in livers of CGL WT and KO mice on
Normal and PTU diets (n = 4–5) (B). The asterisk indicates the significance of the difference relative to CGL WT mice on the Normal diet; *p < 0.05.
(C) Serum T4 levels over a 3-week time course of Normal versus PTU diets in CGL WT and KO mice as indicated (n = 4–5).
(D) Pituitary mRNA expression of TSHa and TSHb in CGLWT and KOmice after 3 weeks of Normal or PTU diet (n = 4–5). The asterisk indicates the significance of
difference between diets within genotype, and the # sign indicates the significance of difference between CGLWT and CGL KOmice on the PTU diet; */#p < 0.05.
(E) Serum TSH levels after 3 weeks of Normal or PTU diet in CGL WT and KO mice (n = 4–5). The asterisk indicates the significance of difference between diets
within genotype, and the # sign indicates the significance of difference between CGL WT and CGL KO mice on the PTU diet; */#p < 0.05.
(F) Percent change in serum T4 levels after 3 days of fasting in CGL WT and CGL KO mice (n = 3–4). The asterisk indicates the significance of the difference
between day 0 and day 3 T4 levels; *p < 0.05.
(G–I) Pituitary GH mRNA expression (n = 4–5) (G), liver GHR and IGF-I mRNA expression (n = 4–5) (H), and serum IGF-1 (n = 4–5) (I) in CGL WT and KO mice after
3 weeks on a Normal or PTU diet as indicated. The asterisk indicates the significance of the difference between diets within genotype, and the # sign indicates the
significance of the difference between genotypes on the PTU diet; */#p < 0.05.
(J) Fold change in serum IGF-I between day 0 and day 3 of a 3-day fast in CGL WT and KO mice (n = 3–4/group). The asterisk indicates the significance of the
difference between day 3 and day 0; *p < 0.05.
(K) Serum IGF-1 levels in mice 7 days after adenoviral infection with Ad-Null control or Ad-CGL overexpression adenovirus expressed relative to Ad-Null control
(n = 4/group). The asterisk indicates the significance of the difference between Ad-Null and Ad-CGL; *p < 0.05.
(L) Fold change in serum IGF-1 after a 2-day fast in female CGL WT and KO mice with +/NaHS supplementation in the CGL KOs (n = 4–5/group). The asterisks
indicate the significance of the difference between serum IGF-1 levels on day 2 compared with day 0; *p < 0.05.
(M) Relationship between diet, GH/TH, and H2S production.
Error bars are ± SEM. See also Figure S7.2014). Hormonally, DR alters hypothalamic activity (Dacks et al.,
2013), lowers GH (Fontana et al., 2008) and TH secretion (Fon-
tana et al., 2006; Miller et al., 2005), and reduces hepatic GHR
expression (Dauncey et al., 1994).In addition to overlap between DR and reduced TH/GH
signaling, genetic models of extended longevity associated
with decreased GH/IGF-1 signaling also have decreased TH
activity (Gesing et al., 2012). Conversely, reduction of THCell Metabolism 25, 1320–1333, June 6, 2017 1329
signaling results in decreased GHR production and signaling
(Dieguez et al., 1986). Re-addition of these hormones into hy-
popituitary dwarf mice individually or in combination reverses
many of the associated phenotypes (Do et al., 2015; Panici
et al., 2010).
Despite these interconnections, here we found distinct, addi-
tive contributions of TH and GH to regulation of H2S production
independent of diet. TH directly regulated CGL and CBS gene
expression via TRb acting as a transcriptional repressor, while
GH via GHR controlled H2S production in an autophagy-depen-
dent manner suggestive of substrate-level control. In addition,
TH negatively regulated protein levels of the ATF4 transcription
factor, a known direct activator of CGL expression (Mistry
et al., 2016). Future experiments are required to determine the
importance of these mechanisms to overall regulation of H2S
production and the contribution of increased H2S to the individ-
ual and shared phenotypes associated with DR and reduced GH
and/or TH signaling. Together, they represent potential target-
able pathways toward harnessing endogenous H2S production
for beneficial outcomes.
Inhibition of TH andGHActivity as a Novel Mechanism of
H2S Action
Reduced insulin/IGF-1 signaling, often accompanied by reduced
circulating levels of these hormones and increased sensitivity to
their action, is a feature shared by multiple rodent models of
extended longevity. Our finding that H2S is required in certain
contexts for downregulation of IGF-1 production suggests con-
trol of IGF-1 as a novel mechanism by which H2S can exert its
pleiotropic effects on health and longevity.
By what mechanism could H2S control hepatic IGF-1 produc-
tion? The observation that CGL was required for lowering
circulating levels of T4 and IGF-1 in two different models of hypo-
thyroidism, combined with the ability of TH to activate GHR/
IGF-1 gene expression (Koenig et al., 1987; Tsukada et al.,
1998), suggests that the compromised ability to reduce circu-
lating T4 may be partially responsible. Consistent with the poten-
tial of H2S to affect TH, H2S donors present in garlic suppress TH
signaling in rats (Tahiliani and Kar, 2003), and addition of NaHS
blocks the production and/or secretion of GH from pituitary-
derived cells (Mustafina et al., 2015). Similarly, we found that
increased CGL expression and/or exogenous H2S addition
were sufficient to decrease circulating TH and IGF-1 in vivo (Fig-
ures 7 and S7).
Finally, we note that while a reduction in circulating IGF-1,
which is produced mainly by liver, correlates with extended
longevity, hepatic IGF-1 expression (and hence circulating
IGF-1) can be reduced without longevity benefits, as in liver-spe-
cific IGF-1KO mice (Yakar et al., 1999). Future studies are
required to determine the relative importance of hepatic H2S pro-
duction on lifespan, as well as the effects of TH/GH signaling on
H2S production in other tissue types.
Implications for Human Health
While GH and TH signaling both decrease with age, it remains
unclear if these changes are adaptive or maladaptive, and if pre-
venting this decline alters healthy aging. GH supplementation
results in increased lean body mass, decreased fat mass, and
gains in muscle strength. However, it is also associated with1330 Cell Metabolism 25, 1320–1333, June 6, 2017edema, carpal tunnel syndrome, joint pain, and an increase in
type 2 diabetes and glucose intolerance (Liu et al., 2007).
Increased TH results in DNA damage and premature senes-
cence in vitro and in vivo (Zambrano et al., 2014). Here we
show that GH and TH supplementation suppresses H2S produc-
tion. Because H2S is positively correlated with improved stress
resistance and health, our findings raise concerns about the
use of GH and/or TH supplementation as anti-aging or perfor-
mance-enhancing therapies.
Conclusions
Previously we found that increased endogenous H2S produc-
tion is in part responsible for the pleiotropic effects of DR.
Here we found that TH and GH, two endocrine hormones asso-
ciated with longevity control, are regulators of hepatic H2S pro-
duction. TH and GH independently and additively suppressed
H2S production through inhibition of CGL gene expression
and control of substrate availability via autophagy, respectively.
Unexpectedly, CGL-dependent H2S itself was required for
feedback regulation of TH signaling via negative regulation
of T4 levels and GH signaling through negative regulation of
IGF-1. Together, these data point to H2S as a potential down-
stream mediator of benefits shared between decreased GH/
TH signaling and DR.
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Antibodies
Anti-CGL (Anti-Cystathionase) Abcam Ab151769
Anti-CBS Abcam Ab135626
Anti-3MST (Anti-MPST) Sigma HPA001240
Anti-Stat5 Santa Cruz Sc-835
Anti-p-Stat5 Cell Signaling Technology 9359
Anti-GNMT Aviva ARP43565_P050
Anti-AHCY Abcam Ab56146
Anti-ATF4 (Anti-CREB-2) Santa Cruz Sc-200
Anti ATG5 Novus NB110-53818
Anti ATG7 Sigma A2856
Anti-beta Tubulin Cell Signaling 2128
Anti-Actin Cell Signaling 4970
HRP conjugated anti-rabbit Dako P044801-2
Bacterial and Virus Strains
Ad-CMV-CGL (Ad-mCTH) Vector Biolabs ADV-256305
Ad-CMV-Null Vector Biolabs 1300
Lentiviral sh-GFP Laboratory of Dr. Alec Kimmelman N/A
Lentiviral sh-ATG5 Laboratory of Dr. Alec Kimmelman N/A
Lentiviral sh-ATG7 Laboratory of Dr. Alec Kimmelman N/A
Biological Samples
Livers (frozen) taken from experimental
mouse strains listed in the Experimental
Models: Organisms/Strains section
See Experimental Models:
Organisms/Strains section
See Experimental Models:
Organisms/Strains section
Serum/Plasma (frozen) taken from
experimental mouse strains listed
in the Experimental Models: Organisms/
Strains section
See Experimental Models:
Organisms/Strains section
See Experimental Models:
Organisms/Strains section
Chemicals, Peptides, and Recombinant Proteins
NaHS Sigma 161527
GYY4137 Sigma SML0100
Lanreotide Sigma SML0132
PTU/LID diet Harlan Teklad TD 95125
T3 (Triiodo-L—thyronine) Sigma T2752
GC-1 Laboratory of Dr. Thomas Scanlan Chiellini et al., 1998
GH (growth hormone) Sigma S8648
FGF21 Genscript Z03290
Bafilomycin Sigma B1793
Chloroquine Sigma C6628
DL-Propargylglycine Sigma P7888
Aminooxyacetic acid Sigma C13408
AZD1480 Selleckchem S2162
Passive Lysis Buffer (5x) Promega E1941
PLP (Pyridoxal 50-phosphate) Sigma P9255
L-cysteine Sigma C7352
lead (II) acetate trihydrate Sigma 316512
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P3 H2S Detection Probe From the lab of Prof. K.H. Ahn Singha et al., 2015
Critical Commercial Assays
Mouse/Rat IGF-1 ELISA kit R&D Systems SMG100
T4 ELISA kit Diagnostic Automation/ Cortez
Diagnostics, Inc
3149-18
MILLIPLEX MAP Mouse Endocrine
(TSH) Assay
EMD Millipore MPTMAG-49K
Experimental Models: Cell Lines
Hepa1-6 2Cl BirA/TRbeta Laboratory of Dr. Anthony N. Hollenberg N/A
Hepa1-6 (mouse liver hepatoma) ATCC CRL-1830
Primary mouse hepatocytes prepared from
C57BL/6 mice (freshly isolated in the lab of
Dr. James Mitchell for each experiment)
Jackson Laboratories and laboratory
of Dr. James R. Mitchell
000664 and this paper
ATG5 Knockout mouse embryonic
fibroblasts
From the laboratory
of Dr. Gokhan Hotamisligil
Yang et al., 2010
ATG7 Knockout mouse embryonic
fibroblasts
From the laboratory
of Dr. Gokhan Hotamisligil
Yang et al., 2010
Primary CGL WT and KO mouse tail
dermal fibroblasts
From the laboratory
of Dr. James R. Mitchell
This paper
Experimental Models: Organisms/Strains
129/C57BL/6 background WT and KO
CGL Male and Female Mice
Laboratories of Dr. Rui Wang
and Dr. James R. Mitchell
Hine et al., 2015;
Yang et al., 2008
WT and LirKO Female Mice Laboratory of Dr. James R. Mitchell Harputlugil et al., 2014
Male and Female WT and Snell Dwarf mice Laboratory of Dr. Richard Miller Dozmorov et al., 2002
Female WT and Ames Dwarf mice Laboratory of Dr. Andrzej Bartke Panici et al., 2010
Male and Female WT and GHRKO Mice Laboratory of Dr. Richard Miller Wang and Miller, 2012
Male and Female WT and IRS-1 KO mice Laboratory of Dr. Colin Selman Selman et al., 2008
Male WT and FGF21 overexpressing mice Laboratory of Dr. Pavlos Pissios Kharitonenkov et al., 2005
TRbeta NI/NI, NI/PV, and mutant
PV/PV mice
Laboratory of Dr. Sheu-yann Cheng (Kato et al., 2004
C57BL/6 mice Jackson Laboratories 000664
B6D2F1 hybrid mice Jackson Laboratories 100006
Oligonucleotides
IGF-1 F: TGCTTGCTCACCTTCACCA IGF-1
R: CAACACTCATCCACAATGCC
N/A N/A
GHR F: ATTCACCAAGTGTCGTTCCCGHR
R: TCCATTCCTGGGTCCATTCA
N/A N/A
CGL F: TTGGATCGAAACACCCACAAA
CGL R: AGCCGACTATTGAGGTCATCA
N/A N/A
CBS F: GGGACAAGGATCGAGTCTGGA
CBS R: AGCACTGTGTGATAATGTGGG
N/A N/A
HPRT F:TTTCCCTGGTTAAGCAGTACA
GCCC HPRT R:TGGCCTGTATCCAACAC
TTCGAGA
N/A N/A
RPL13 F:TTCGGCTGAAGCCTACCA
GAAAGT RPL13 R:TCTTCCGATAGT
GCATCTTGGCCT
N/A N/A
MAT1A F: GATAGCAGATCTGAGGCGCT
MAT1A R: TGCACCATTATCCTGCATGT
N/A N/A
GNMT F: AAGAGGGCTTCAGCGTGATG
GNMT R: CTGGCAAGTGAGCAAAACTGT
N/A N/A
(Continued on next page)
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AHCY F: CGCCAGCATGTCTGATAAAC
AHCY R: CCTGGCATCTCATTCTCAGC
N/A N/A
BHMT F: TTAGAACGCTTAAATGCCGGAG
BHMT R: GATGAAGCTGACGAACTGCCT
N/A N/A
For a full list of all primers used, please see
Table S1
Software and Algorithms
ImageJ National Institutes of Health Windows version,
https://imagej.nih.gov/ij/
download.htmlCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, James R.
Mitchell (jmitchel@hsph.harvard.edu)
EXPERIMENTAL MODELS
In Vivo Animal Studies
All experiments were performed with the approval of the Institutional Animal Care and Use Committee (IACUC) from the respective
institutions. Except where indicated in this paper or cited in the respective references, animals were bred andmaintained under stan-
dard housing conditions with ad libitum access to food (Purina 5058) and water, 12-hour light/12-hour dark cycles, temperature be-
tween 20–23C with 30%–70% relative humidity, and weaned from their mothers between 3-4 weeks of age. Mice used included:
young adult (10-15 week old) male and (1-year old) female CGLKO and WT control mice on a mixed 129/C57BL/6 background
(Hine et al., 2015; Yang et al., 2008); female (10-16 week old) LIrKO and control mice generated by crossing Irfl/fl (WT) mice with
Irfl/fljAlbumin-Cre+/ (LIrKO) mice as previously described (Harputlugil et al., 2014); male and female Snell Dwarf and WT littermates
aged 4-5 months (Dozmorov et al., 2002); 18-month female Ames Dwarf and WT littermates treated daily with recombinant growth
hormone during a 6-week period early in life (weeks 2-8) as described (Panici et al., 2010), male and female GHRKO and WT litter-
mates aged 7-8 months (Wang and Miller, 2012), sixteen week old male and female IRS-1 KO and WT littermates (Selman et al.,
2008); male FGF21 overexpressing (OE) transgenic andWT littermates (Kharitonenkov et al., 2005) and TRbWT (NI/NI), heterozygote
(NI/PV) and Mutant (PV/PV) mice as previously described (Kato et al., 2004).
Lanreotide (Sigma) was administered to 10 week old male WT B6D2F1 hybrids (Jackson Labs) via daily sub-cutaneous injection at
0.4 mg/kg (Fan et al., 1996) in sterile saline once/day for 7 days prior to euthanasia and organ harvest. CGL was overexpressed by IV
injection of 1010 PFUs of Ad-CMV-CGL (ADV-256305) or control Ad-CMV-Null virus (Vector Biolabs) into 10 week old male WT
B6D2F1 hybrids as previously described (Hine et al., 2015) 7 days prior to blood serum collection for IGF-1 determination. Hydrogen
sulfide supplementation was performed in male C57BL/6 mice (Jackson) using NaHS (Sigma) (1mM) and GYY4137 (Sigma) (260mM)
in the drinking water starting at 10 weeks of age for 2 weeks, with supplementation of additional NaHS every two days and GYY4137
after the first week and with blood taken for analysis on day 0, 7, and 14. Young adult (10 to 15 weeks of age) male CGL WT and KO
mice were fasted of food for three days with ad libitum access to drinking water and blood/serum sampled at Day 0 and Day 3.
1-year old female CGLWTand KOmicewere fasted of food for two-days and given ad libitum access to drinkingwater, and then blood
taken onDay 0 andDay 2,with one of the twoCGLKOgroups receivingNaHS injection in sterile saline at a dose of 5mg/kg per injection
after the first blooddrawonday 0, day 1, and just prior to harvest onday2. 10-weekoldmaleB6D2F1hybridswere kept on an ad libitum
rodent diet and injected with NaHS in sterile saline at 5mg/kg and blood/serum taken 24-hours later for analysis. Recombinant human
IGF-1 (rhIGF-1) at 500mg/kg/dor recombinant humangrowthhormone (rhGH) at 2mgkg/day (BID)were administeredby intraperitoneal
injection for 20 days in 12-week-old male C57BL/6 mice as described (Lee et al., 2014). Modulation of thyroid hormone levels on a
hypothyroid background was accomplished in 9-week old male C57BL6 mice maintained for 3 weeks on a PTU/LID diet (Harlan
Teklad formula # TD 95125) to induce hypothyroidism followed by saline or T3 (Sigma, St. Louis, MO) intraperitoneal injection once a
day for 4 days to create hypothyroid (saline), euthyroid (0.5 mg/100g bodyweight of T3) or hyperthyroid (25 mg/100g bodyweight of
T3) mice. For modulation of thyroid hormone levels on a euthyroid background, 10week oldmalemice fed a standard rodent diet (Lab-
diet Chow) were injected intraperitoneally with saline or 25 mg/100g bodyweight of T3 once a day for 4 days. GC-1 (Chiellini et al., 1998)
was administered to 10-week old male C57BL6 mice fed a standard rodent diet (Labdiet Chow) by intraperitoneal injection (3 mg/100g
bodyweight) once a day for 4 days.
Cell Lines and In Vitro Tissue Culture Studies
Mouse primary hepatocytes from 8-10 week old female WT C57BL/6 mice (Jackson Laboratories) were isolated via portal vein colla-
genase treatment (Liberase, Roche) followed by Percoll gradient centrifugation and culturing in William’s E media with 5% FBS ate3 Cell Metabolism 25, 1320–1333.e1–e5, June 6, 2017
37C, 20% O2 and 5% CO2. The Hepa1-6 cell line, originally obtained from a C57L mouse (sex unknown), was maintained in DMEM
media with 10% FBS. Hepa1-6 2Cl BirA/TRb cells, which were generated by sequentially transfecting BirA And TRb into Hepa 1-6
cells and selecting clones using geneticin and puromycin, weremaintained in DMEM+Glutamax with 10% vol/vol FBS supplemented
withGibco Antibiotic-Antimycotic, Geneticin, and Puromycin at 37C, 20%O2 and 5%CO2. Lentiviral infections of Hepa1-6 cells with
sh-GFP, sh-ATG5 or sh-ATG7were performed in the presence of 10%FBS and 8mg/ml Polybrene on two consecutive days; infected
Hepa1-6 cells were selected with 3mg/ml puromycin for 2 weeks before use andmaintained with 3mg/ml puromycin. Genetically defi-
cient ATG5 fibroblasts originally from 129/C57BL mixed background embryos (sex unknown) and ATG7 fibroblasts originally from
C57BL/6 embryos (sex unknown) were a gift from the lab of Dr. Gokhan Hotamisligil and previously reported (Yang et al., 2010).
CGL WT and KO mouse dermal fibroblasts from tail skin were prepared from female CGL WT and KO mice and maintained in
20% FBS in DMEM +Penicillin/Streptomycin. For differential H2S determination, an equal number of cells were seeded onto 12-
well plates and incubated overnight in media +/- serum with or without the following drugs/hormones: GH (0.1-1mg/mL, Sigma),
FGF21 (100nM, Genscript), T3 (10&100nM, Sigma), Bafilomycin (1mM, Sigma), Chloroquine (10mM, Sigma), DL-Propargylglycine
(PAG) (100mM, Sigma), Aminooxyacetic acid (AOAA) (100mM, Sigma), AZD1480 (10mM, Selleckchem).
METHOD DETAILS
Lead Sulfide Method for Determination of H2S Production Capacity
H2S production capacity in liver homogenates was measured as previously described (Hine et al., 2015). Briefly, fresh or flash frozen
liver was homogenized in passive lysis buffer (Promega) and volume normalized to protein content. An equal volume/protein amount
was added to a reaction master mix containing PBS, 1mM Pyridoxal 50-phosphate (PLP) (Sigma) and 10mMCys (Sigma) and placed
in a well-format (12-well to 96-well) plate. H2S detection paper, saturated with lead acetate and then dried, was placed above the
plate and incubated 1-2hrs at 37C until H2S in the gas phase reacted with the paper to form dark lead sulfide. In live primary hepa-
tocytes, growth media was supplemented with 10mM Cys and 10mM PLP, and a lead acetate H2S detection paper placed over the
plate for 2-24hrs at 37C in a CO2 incubator.
H2S Detection with Fluorescent Probe
Cultured Cells
The chemical H2S probe P3 (Singha et al., 2015) was added at 10mM final concentration directly to the cell culture media following
overnight treatment of cells (e.g. +/- serum, +/- hormones/drugs). One hour after P3 addition, H2S-activated P3 fluorescence was
quantitated on a BioTek plate reader (excitation 360nm, emission 528nm). Alternately, cells were washed 1x with PBS, fixed in
ice-cold methanol for 10 minutes, dried, and stored at -20C until imaging via 2-photon microscopy (Mai Tai, Spectra-Physics)
with excitation at 880 nm and emission 520-530nm using a 10x objective following rehydration in 1x PBS. Images were analyzed us-
ing the Integrated Density (IntDen) function of ImageJ software to determine the total florescence of the entire image.
Liver Ex Vivo Analysis
Flash frozen liver from adult maleWT or Snell Dwarf mice was embedded in OCTmedia and cryosectioned onto glass slides, thawed
to room temp and incubated in PBS containing 10mM P3 at room temperature for 30 minutes prior to fixation and then subsequent
imaging via 2-photon microscopy using a 60x objective. The fluorescence signal was determined using the Integrated Density
(IntDen) function of ImageJ obtained from analyzing the entire image and averaging three images per animal and three animals/group.
These values were then normalized to the average wildtype control value (set to 1).
PTU/LID Diet for Altering Thyroid State
10-15 week old WT or CGLKOmale mice were given ad libitum access to the Normal control 5058 diet (Purina), or the low iodine diet
with 0.15% PTU; PTU/LID (Harlan Teklad) for three weeks prior to assay or harvest.
Western Blots/Protein Analysis
Protein analysis was performed via western blot on tissue and cell homogenates in passive lysis buffer (Promega), separated by SDS-
PAGE, transferred to PVDF membrane (Whatman) and blotted for CGL (ab151769 Abcam), CBS (ab135626 Abcam), 3MST
(HPA001240 Sigma), Stat5 (sc-835 Santa Cruz), p-Stat5 (#9359 Cell Signaling Technology), GNMT (Aviva), AHCY (Abcam
ab56146), ATF4 (aka CREB-2 C-20, Santa Cruz Biotechnology sc-200), ATG5 (Novus, NB110-53818), ATG7 (Sigma, A2856),
b-Tubulin 9F3 (#2128 Cell Signaling) or Actin (#4970 Cell Signaling) followed by HRP conjugated secondary anti-rabbit anti-
body (Dako).
qPCR/mRNA Analysis
Total RNA was isolated from tissues and cells using standard phenol-chloroform/isopropanol extraction and cDNA synthesized by
random hexamer priming with the Verso cDNA kit (Thermo). qRT-PCRwas performed with SYBR green dye (Lonza) and TaqPro DNA
polymerase (Denville) or Taqman Universal PCR Master Mix (Thermo Fisher Scientific). Fold changes were calculated by the DDCt
method using the genes Hprt and/or Rpl13 as controls and ultimately normalized to the control for each respective experiment, or
normalized to a standard curve utilizing cyclophilin as an internal control. Primer sets used for PCR are listed in the Key Resources
Table and in Table S1.Cell Metabolism 25, 1320–1333.e1–e5, June 6, 2017 e4
ChIP of TRb
TRb1-binding sites in gnmt, cth, cbs, mat1a and bhmt were identified in a previous study that characterized the cistrome of TRb1 in
mouse liver (Ramadoss et al., 2014). ChIP-qPCR was performed as previously described. Briefly, hypothyroid mice that expressed
BirA ubiquitously were transduced with an adenovirus expressing wither GFP alone or Blrp-TRb1 and GFP together. Subsequently
half the hypothyroid mice in each group were given T3 injections to render them hyperthyroid. Livers from these mice were collected
for chromatin affinity precipitation using streptavidin-agarose beads and qPCR was performed using primer sequences directed
against genomic sites identified by ChIP-seq analysis.
Liver Metabolomics
Ex vivomouse liver polar metabolomics was performed using targeted tandemmass spectrometry (LC-MS/MS) with polarity switch-
ing and selected reaction monitoring (SRM) with a AB/SCIEX 5500 QTRAP Mass spectrometer as previously described in (Yuan
et al., 2012).
Detection of Serum Hormones: IGF-1, T4, TSH
Serum IGF-1 was detected using the IGF-1 Mouse/Rat ELISA kit (R&D Systems) following the manufacturer’s recommendations.
Total plasma T4 levels were measured using a commercially available ELISA Kit (Diagnostic Automation/ Cortez Diagnostics, Inc
Calabasas, CA). Thyroid-stimulating hormone (TSH) was measured in plasma via Milliplex MAP (mutianalyte panels) (mouse thyroid
hormone TSH panel; EMD Millipore, Billerica, MA).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are displayed as means +/- standard error of the mean (SEM) and statistical significance assessed in GraphPad Prism and/or
Microsoft Excel using Student’s t tests to compare values between two specific groups, and one-way or two-way ANOVA followed by
Tukey’s or Sidak’s Multiple Comparisons Tests when comparing more than two groups/variables at a given time. A P-value of 0.05 or
less was deemed statistically significant in all of these statistical tests. Statistical details and results of experiments are found in the
figures and figure legends. Quantification of western blot images, lead sulfide H2S production capacity assays, and 2-photon H2S
production images was done using the IntDen measurement in ImageJ software and normalized to the respective control group
in each experiment when applicable. All experiments examining hepatic H2S production were initially performed in a blinded fashion
and technical repeats were done at least twice. Snell Dwarf andGHRKOexperiments were repeated twice independently for a total of
6/genotype per sex or 12 total/genotype, and PTU/LID diet experiments in CGLWT and KOmice were repeated independently three
times for a total of 11-12 animals/group.e5 Cell Metabolism 25, 1320–1333.e1–e5, June 6, 2017
